Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China
· Delayed Price · Currency is CNY 15.64
+0.13 (0.84%)
At close: Dec 5, 2025
SHE:300601 Revenue
Shenzhen Kangtai Biological Products had revenue of 671.38M CNY in the quarter ending September 30, 2025, a decrease of -17.74%. This brings the company's revenue in the last twelve months to 2.70B, down -11.03% year-over-year. In the year 2024, Shenzhen Kangtai Biological Products had annual revenue of 2.65B, down -23.75%.
Revenue (ttm)
2.70B
Revenue Growth
-11.03%
P/S Ratio
6.48
Revenue / Employee
1.41M
Employees
1,913
Market Cap
17.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.65B | -825.72M | -23.75% |
| Dec 31, 2023 | 3.48B | 320.04M | 10.14% |
| Jan 1, 2023 | 3.16B | -494.69M | -13.55% |
| Jan 1, 2022 | 3.65B | 1.39B | 61.51% |
| Dec 31, 2020 | 2.26B | 317.85M | 16.36% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Aier Eye Hospital Group | 22.17B |
| Shanghai United Imaging Healthcare | 12.20B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |